Obstetrics/Gynecology
RSSArticles
-
Maternal Mortality, Postpartum Hemorrhage, and Tranexamic Acid: The WOMAN Study
A multicenter study involving patients in 193 countries has shown a decrease in maternal mortality in women with postpartum hemorrhage who were given tranexamic acid once the diagnosis was made.
-
House Healthcare Bill Would Undermine Reproductive Health
GOP efforts to repeal and replace the Affordable Care Act could directly and indirectly imperil coverage for and access to reproductive healthcare under Medicaid and private insurance.
-
Report: Hepatitis C Rates on the Rise Among Reproductive-aged Women
The incidence of hepatitis C virus infection has increased among young people who inject drugs, about half of whom are women of reproductive age, according to the CDC.
-
Hot Flashes Appear Linked to Cardiovascular Changes
New data suggest that, particularly for younger midlife women, frequent hot flashes may indicate emerging vascular dysfunction that can lead to heart disease.
-
Talk to Young Adults About Importance of Sexually Transmitted Infection Testing
When it comes to sexually transmitted infections, young adults are most at risk, with one in two sexually active people contracting an infection by age 25.
-
Women with Predisposition to Fractures May Benefit from Hormone Therapy
Researchers discovered that women who are genetically at the highest risk of fracture risk can enjoy the greatest protection from fracture when they use hormone therapy.
-
Researchers, Advocates Seek Pathways to Easing Access to Medication Abortion
Considering medical pregnancy termination through an over-the-counter regulatory lens.
-
Research Backs Effectiveness of Putting Implants in Place
New research indicates that the risk of luteal phase pregnancy following any-cycle-day insertion of contraceptive implants with negative pregnancy testing is low, regardless of menstrual cycle timing, recent contraceptive use, or use of emergency contraception.
-
Obesity and Endometrial Cancer
Obesity is a major risk factor for endometrial cancer as well as for other major comorbidities.
-
Oral Contraceptives and Quality of Life
In this three-month randomized, double-blind trial comparing oral contraceptives to placebo, the authors found a small decrease in general well-being scores but no effect on depressive symptoms. The short time period and small effect size introduce doubt into the validity of these findings.